NCT06314529View on ClinicalTrials.gov

Long-term Follow-up Study of BHC001 for TDT

RecruitingOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

December 10, 2036

Study Completion Date

May 10, 2037

Conditions
Thalassemia, Beta
Interventions
OTHER

Assessments

Safety and efficacy assessments

Trial Locations (2)

510510

RECRUITING

Xiangya Hospital of Central South University, Changsha

530021

RECRUITING

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Nanning

Sponsors
All Listed Sponsors
collaborator

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

lead

Bioray Laboratories

INDUSTRY

NCT06314529 - Long-term Follow-up Study of BHC001 for TDT | Biotech Hunter | Biotech Hunter